Back to Search
SIMI MATHEW, MD
MD
Hospitalist Physician
NPI: 1598339996IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
2024026060(MO)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4351047723(MI)4351047723(MO)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
4351047723
CMS Specialties
PrimaryHOSPITALIST
Education
OTHER
Class of 2019
Research & Publications (20)
A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder.
PMID 19204062·J Psychopharmacol·2010
8-other
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.
PMID 19288975·Int J Neuropsychopharmacol·2010
2-rct
Functional role of human NK cell receptor 2B4 (CD244) isoforms.
PMID 19499526·Eur J Immunol·2009
8-other
Differential regulation of cell type-specific apoptosis by stromelysin-3: a potential mechanism via the cleavage of the laminin receptor during tail resorption in Xenopus laevis.
PMID 19429683·J Biol Chem·2009
7-preclinical
Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study.
PMID 18942064·NMR Biomed·2009
4-observational
Treatment-resistant depression: recent developments and future directions.
PMID 19058261·Depress Anxiety·2008
6-review
Novel drugs and therapeutic targets for severe mood disorders.
PMID 18172433·Neuropsychopharmacology·2008
6-review
Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study.
PMID 18840371·Clin Ther·2008
3-trial
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.
PMID 18028881·Biol Psychiatry·2008
2-rct
Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.
PMID 18412102·Am J Med Genet C Semin Med Genet·2008
6-review
Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element.
PMID 17300754·Biochem Biophys Res Commun·2007
8-other
A rapid spectrophotometric assay of some organophosphorus pesticide residues in vegetable samples.
PMID 17267272·Spectrochim Acta A Mol Biomol Spectrosc·2007
8-other
Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
PMID 16884397·Eur J Clin Invest·2006
7-preclinical
Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
PMID 16002700·J Immunol·2005
7-preclinical
Glutamate modulators as novel interventions for mood disorders.
PMID 16224615·Braz J Psychiatry·2005
6-review
Formulation and in vitro-in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration.
PMID 19606940·J Microencapsul·2009
7-preclinical
Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.
PMID 19633642·Mod Pathol·2009
8-other
Repression of the cardiac myosin light chain-2 gene in skeletal muscle requires site-specific association of antithetic regulator, Nished, and HDACs.
PMID 19604314·J Cell Mol Med·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6420 CLAYTON RD
SAINT LOUIS, MO 63117 - Phone
- (314) 768-8000
Quick Facts
- NPI
- 1598339996
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile